SU2C CATALYST RESEARCH GRANT PROGRAM WITH SUPPORT FROM ZENTALIS PHARMACEUTICALS

ENTERTAINMENT INDUSTRY FOUNDATION

Objecte

Topic: Cancer.

Destination: Support projects that investigate the use of Wee1 inhibitors to treat different types of cancer.

Budget: $800,000.

Duration: 3 years.

Are you interested in this call?

Estàs interessat?

Omple el següent formulari per rebre més informació: